Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy
Price: $ 15.50
4.8(688)
Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response
Ketoprofen, CAS 22071-15-4
Inhibition of ROS production, autophagy or apoptosis signaling reversed the anticancer properties of Antrodia salmonea in triple-negative breast cancer (MDA-MB-231) cells - ScienceDirect
Biomedical nanomaterials for immunological applications: ongoing research and clinical trials - Nanoscale Advances (RSC Publishing) DOI:10.1039/D0NA00478B
WO2020061349A1 - Diagnostic methods for triple-negative breast cancer - Google Patents
Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands - ScienceDirect
Cancers, Free Full-Text
Hydrogen Sulfide in Biochemistry and Medicine
Inhibiting ACAT1/SOAT1 in Microglia Stimulates Autophagy-Mediated Lysosomal Proteolysis and Increases Aβ1–42 Clearance
Breast cancer cell lines have a differential sensitivity to autophagy
Role of autophagy in breast cancer and breast cancer stem cells (Review)
Ketoprofen induced apoptosis MD-MB-231 by acting on Fas receptor. The
Cancers, Free Full-Text
